Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (11 quarters reported)
$224M in Q4 2014 → $147M now. Hover for any quarter.
As reported for the quarter ended June 30, 2017. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| T Tesaro Inc | 6.4% | Trimmed 20% | 67,490 | $9.44M |
| CO Clovis Oncology Inc | 6.3% | Trimmed 34% | 99,101 | $9.28M |
| Incyte Corp | 6.2% | Added 3.4% | 72,051 | $9.07M |
| Ironwood Pharmaceuticals Inc | 6.0% | Trimmed 30% | 470,000 | $8.87M |
| WM Wright Med Group N V | 6.0% | Added 4.7% | 320,420 | $8.81M |
| Biomarin Pharmaceutical Inc | 5.8% | Trimmed 10% | 94,454 | $8.58M |
| PH Pra Health Sciences Inc | 5.4% | Trimmed 24% | 106,555 | $7.99M |
| Edwards Lifesciences Corp | 5.4% | Trimmed 25% | 67,266 | $7.95M |
| A Abiomed Inc | 5.4% | Trimmed 26% | 55,387 | $7.94M |
| Nevro Corp | 5.3% | Added 5.0% | 105,000 | $7.82M |
| QN Qiagen Nv | 5.0% | New | 217,954 | $7.31M |
| Smith & Nephew PLC | 4.7% | New | 200,000 | $6.97M |
| PP Portola Pharmaceuticals | 4.6% | New | 120,000 | $6.74M |
| Neurocrine Biosciences Inc | 4.6% | New | 145,303 | $6.68M |
| Brookdale Senior Living Inc | 4.5% | New | 450,000 | $6.62M |
| IP Icon PLC Ord | 4.2% | New | 63,342 | $6.19M |
| Vertex Pharmaceuticals Inc | 4.1% | Trimmed 42% | 46,202 | $5.95M |
| Align Technology Inc | 3.5% | New | 33,904 | $5.09M |
| Illumina Inc | 3.3% | New | 27,500 | $4.77M |
| Intuitive Surgical Inc | 3.2% | New | 5,000 | $4.68M |
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.
quarter ended June 30, 2017 · filed August 11, 2017
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Biogen Inc | Exited | −46,320 | −$12.7M | — |
| GM Globus Med Inc | Exited | −400,000 | −$11.8M | — |
| QN Qiagen Nv | Exited | −390,000 | −$11.3M | — |
| Bristol Myers Squibb Co | Exited | −200,000 | −$10.9M | — |
| BC Bard C R Inc | Exited | −37,419 | −$9.3M | — |
| N Nuvasive Inc | Exited | −123,317 | −$9.21M | — |
| C Celgene Corp | Exited | −72,902 | −$9.07M | — |
| AH Allscripts Healthcare Solutn | Exited | −590,000 | −$7.48M | — |
| QN Qiagen Nv | New | +217,954 | +$7.31M | 5.0% |
| A Akorn Inc | Exited | −300,000 | −$7.22M | — |
Showing the 10 largest of 30 changes.
quarter ended March 31, 2017 · filed May 12, 2017
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Biogen Inc | New | +46,320 | +$12.7M | 6.2% |
| GM Globus Med Inc | New | +400,000 | +$11.8M | 5.8% |
| AP Alexion Pharmaceuticals Inc | Exited | −90,134 | −$11M | — |
| Hologic Inc | Exited | −273,478 | −$11M | — |
| LA Laboratory Corp Amer Hldgs | Exited | −85,000 | −$10.9M | — |
| Boston Scientific Corp | Exited | −498,303 | −$10.8M | — |
| SP Shire PLC | Exited | −62,500 | −$10.6M | — |
| WM Wright Med Group N V | New | +306,165 | +$9.53M | 4.7% |
| CO Clovis Oncology Inc | Trimmed | −148,982 | −$9.49M | 4.7% |
| A Abiomed Inc | New | +75,000 | +$9.39M | 4.6% |
Showing the 10 largest of 27 changes.
quarter ended December 31, 2016 · filed February 13, 2017
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Biogen Inc | Exited | −40,996 | −$12.8M | — |
| Biomarin Pharmaceutical Inc | Exited | −137,595 | −$12.7M | — |
| WM Wright Med Group N V | Exited | −486,180 | −$11.9M | — |
| BC Bard C R Inc | New | +52,377 | +$11.8M | 7.1% |
| Neurocrine Biosciences Inc | Exited | −226,501 | −$11.5M | — |
| AP Alexion Pharmaceuticals Inc | New | +90,134 | +$11M | 6.7% |
| LA Laboratory Corp Amer Hldgs | New | +85,000 | +$10.9M | 6.6% |
| Boston Scientific Corp | New | +498,303 | +$10.8M | 6.5% |
| Illumina Inc | Exited | −59,270 | −$10.8M | — |
| Smith & Nephew PLC | Exited | −325,000 | −$10.7M | — |
Showing the 10 largest of 25 changes.
quarter ended September 30, 2016 · filed November 10, 2016
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| SG Seattle Genetics Inc | Exited | −328,430 | −$13.3M | — |
| MJ Mead Johnson Nutrition Co | Exited | −135,045 | −$12.3M | — |
| Incyte Corp | New | +128,169 | +$12.1M | 6.6% |
| CO Clovis Oncology Inc | New | +335,000 | +$12.1M | 6.6% |
| T Tesaro Inc | New | +120,000 | +$12M | 6.6% |
| WM Wright Med Group N V | New | +486,180 | +$11.9M | 6.5% |
| Hologic Inc | New | +305,474 | +$11.9M | 6.5% |
| A Abiomed Inc | Exited | −104,920 | −$11.5M | — |
| Boston Scientific Corp | Exited | −469,900 | −$11M | — |
| Vertex Pharmaceuticals Inc | Exited | −125,450 | −$10.8M | — |
Showing the 10 largest of 25 changes.
quarter ended June 30, 2016 · filed August 12, 2016
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| CC Cooper Cos Inc | Exited | −92,690 | −$14.3M | — |
| SG Seattle Genetics Inc | New | +328,430 | +$13.3M | 8.7% |
| Ionis Pharmaceuticals Inc | Exited | −318,490 | −$12.9M | — |
| IL Integra Lifesciences Hldgs C | Exited | −180,000 | −$12.1M | — |
| Boston Scientific Corp | New | +469,900 | +$11M | 7.2% |
| Vertex Pharmaceuticals Inc | New | +125,450 | +$10.8M | 7.1% |
| Ironwood Pharmaceuticals Inc | New | +821,070 | +$10.7M | 7.0% |
| QN Qiagen Nv | Exited | −475,000 | −$10.6M | — |
| SJ St Jude Med Inc | Exited | −190,140 | −$10.5M | — |
| Molina Healthcare Inc | New | +205,270 | +$10.2M | 6.7% |
Showing the 10 largest of 24 changes.
quarter ended March 31, 2016 · filed May 13, 2016
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Intuitive Surgical Inc | Exited | −37,000 | −$20.2M | — |
| Edwards Lifesciences Corp | Exited | −252,500 | −$19.9M | — |
| Biogen Inc | Exited | −58,161 | −$17.8M | — |
| EI Endo Intl PLC | Exited | −255,080 | −$15.6M | — |
| B Baxalta Inc | Exited | −385,000 | −$15M | — |
| MJ Mead Johnson Nutrition Co | New | +166,370 | +$14.1M | 9.0% |
| C Cerner Corp | Exited | −216,339 | −$13M | — |
| Ionis Pharmaceuticals Inc | New | +318,490 | +$12.9M | 8.2% |
| Nevro Corp | Exited | −190,000 | −$12.8M | — |
| IL Impax Laboratories Inc | Exited | −295,000 | −$12.6M | — |
Showing the 10 largest of 31 changes.
quarter ended December 31, 2015 · filed February 12, 2016
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| SP Shire PLC | New | +92,030 | +$18.9M | 6.4% |
| Incyte Corp | Exited | −144,710 | −$16M | — |
| EI Endo Intl PLC | New | +255,080 | +$15.6M | 5.3% |
| B Baxalta Inc | New | +385,000 | +$15M | 5.1% |
| Biomarin Pharmaceutical Inc | Exited | −139,164 | −$14.7M | — |
| AP Alexion Pharmaceuticals Inc | Exited | −89,884 | −$14.1M | — |
| N Nuvasive Inc | Exited | −285,000 | −$13.7M | — |
| WH Wellcare Health Plans Inc | Exited | −150,000 | −$12.9M | — |
| BS Brookdale Sr Living Inc | Exited | −560,220 | −$12.9M | — |
| Nevro Corp | New | +190,000 | +$12.8M | 4.3% |
Showing the 10 largest of 32 changes.
quarter ended September 30, 2015 · filed November 13, 2015
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| CC Cigna Corporation | Exited | −124,312 | −$20.1M | — |
| A Aetna Inc | Exited | −150,187 | −$19.1M | — |
| Humana Inc | Exited | −100,000 | −$19.1M | — |
| HN Health Net Inc | Exited | −255,814 | −$16.4M | — |
| MN Mylan N V | Exited | −240,000 | −$16.3M | — |
| Incyte Corp | New | +144,710 | +$16M | 6.3% |
| SP Shire PLC | Exited | −65,638 | −$15.9M | — |
| R Receptos Inc | Exited | −80,000 | −$15.2M | — |
| IL Impax Laboratories Inc | Exited | −325,000 | −$14.9M | — |
| Intuitive Surgical Inc | New | +30,000 | +$13.8M | 5.4% |
Showing the 10 largest of 34 changes.
Loading...
